Creative Biolabs has announced the expansion of its custom oligosaccharide synthesis and glycan characterization services, targeting the growing demand for structurally defined glycans in drug discovery. Oligosaccharides are essential in cell signaling, immune regulation, and disease progression, yet their structural complexity often hampers synthesis, purification, and analysis. By combining chemical, enzymatic, and chemoenzymatic synthesis with advanced analytical platforms, Creative Biolabs aims to provide researchers with highly characterized oligosaccharides for reliable downstream studies.
The importance of this announcement lies in the critical role glycans play in therapeutic development, including vaccines and biomarker discovery. The company's integrated approach reduces technical risks and improves experimental reproducibility, enabling more efficient project progression. According to a scientist from Creative Biolabs, the structural complexity of oligosaccharides presents significant challenges, but integrating custom synthesis with comprehensive analytical characterization helps researchers obtain structurally validated glycans that accelerate scientific discovery.
Creative Biolabs offers a broad portfolio of services, including custom oligosaccharide synthesis of high-purity oligosaccharides, complex glycans, tumor-associated carbohydrate antigens (TACAs), and functionalized derivatives. Advanced glycan characterization utilizes mass spectrometry (MS), high-performance liquid chromatography (HPLC), and nuclear magnetic resonance (NMR) to determine structures, linkage patterns, sequences, and purity. The company also provides application-oriented carbohydrate design for structural biology, glycoprotein research, biomarker discovery, immunology, targeted drug delivery, and therapeutic development.
Researchers have highlighted the quality of synthesized products and comprehensive technical support. In one project, a complex glycan structure unavailable through standard commercial sources was successfully produced and validated through integrated synthesis and analytical characterization, supporting downstream structural confirmation. This capability is particularly valuable as glycan-based therapeutics and biomarker studies gain momentum, requiring structurally defined oligosaccharides with reliable analytical validation.
By combining custom carbohydrate synthesis with rigorous analytical characterization under one platform, Creative Biolabs helps researchers reduce technical risks, improve experimental reproducibility, and support more efficient project progression. The integrated platform is designed to accelerate scientific innovation in glycobiology and glycomics. Researchers can explore customized oligosaccharide synthesis and glycan characterization options through Creative Biolabs' glycobiology platform at https://www.creative-biolabs.com/glycoprotein/.
